NEI
MIRM icon

Northwest & Ethical Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

Northwest & Ethical Investments’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Sell
896
-2,704
-75% -$271K ﹤0.01% 472
2026
Q1 		$346K Buy
+3,600
New +$339K 0.01% 436

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northwest & Ethical Investments's MIRM Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Mirum Pharmaceuticals (MIRM) stake by 75% in Q2 2026, selling an estimated $271K and leaving 896 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #472.

Northwest & Ethical Investments first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. The position peaked at $346K in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Northwest & Ethical Investments held 896 shares of Mirum Pharmaceuticals worth $110K as of Q2 2026.
  • Northwest & Ethical Investments sold 2,704 Mirum Pharmaceuticals shares in Q2 2026, an estimated $271K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Northwest & Ethical Investments's portfolio in Q2 2026, its #472 holding.
  • Northwest & Ethical Investments first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Northwest & Ethical Investments's Mirum Pharmaceuticals position peaked at $346K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.